Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
about
Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient miceStructural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery.Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice.Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites.IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.Pneumocystis infection in an immunocompetent host can promote collateral sensitization to respiratory antigens.The role of macrophage IL-10/innate IFN interplay during virus-induced asthma.Chlamydia muridarum infection elicits a beta interferon response in murine oviduct epithelial cells dependent on interferon regulatory factor 3 and TRIFPulmonary hypertension can be a sequela of prior Pneumocystis pneumonia.Current understanding of Pneumocystis immunology.Pneumocystis infection enhances antibody-mediated resistance to a subsequent influenza infection.Parenchymal cell TNF receptors contribute to inflammatory cell recruitment and respiratory failure in Pneumocystis carinii-induced pneumonia.Type I Interferons as Regulators of Lung Inflammation.Cytokines and the regulation of fungus-specific CD4 T cell differentiation.Induction and function of IFNβ during viral and bacterial infection.The interferons and their receptors--distribution and regulation.The role of innate immune signals in immunity to Brucella abortus.Pneumocystis infection alters the activation state of pulmonary macrophages.Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during PneumoniaB cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent.Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.STAT4-dependent and -independent Th2 responses correlate with protective immunity against lung infection with Pneumocystis murina.Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection.
P2860
Q24651329-5708F57C-780F-484C-AF1C-5399F3945352Q27687338-472D5D97-0850-4F9E-B4C4-F8381C34B535Q33490848-A18811BA-F522-4C5F-A06E-0496BA562AFAQ33593887-4569D77E-D0BF-430C-9DB9-2806C36F08BDQ33882469-724C888A-D238-4258-88F9-F140F966391CQ34155021-E6B1FEFA-FE24-4F44-BE1D-316C00C2807CQ34762141-AD5B06EE-5B09-41A3-A293-9B44084A8838Q34931718-4BC7F528-DBA0-40A9-9B71-DA2481115D65Q35046046-AD169302-0D7B-4BE0-8DE3-E0B544E7BB12Q35689398-0444B7F3-62E4-4F41-9D7E-B6927200FB9DQ35963236-A5E98A3D-51BB-4A40-BC63-D3D9B9122F26Q36984703-118160E4-FC13-4AF4-A851-432876F4EF49Q37010665-8FB30D1A-89CB-476E-9686-D79ED2E7F7D3Q37163093-3B530133-7295-495E-819D-B8A9D20B093AQ37691992-D27EDFF1-BCA0-4FF5-8F59-C7CC56520CA6Q37963574-8D1F2B4D-8A5C-436B-8B8C-BD0111CF5911Q37982838-E16DA32B-B1DC-414D-8FFB-C285ACAD660EQ37992849-C1450242-3000-4CE8-A08A-AC8D52EBF754Q38056731-2E02A271-624E-45DF-B885-C1EDDF8CEC9DQ39308787-2C8CFFFB-B6E3-476F-A22D-2D321C8EAC34Q40403699-4EE063CC-7D7F-485B-A356-3B2FCE479251Q41632240-98A8C884-26BD-4B91-B8BF-DED90E30EA2DQ41985907-195180FF-C045-4113-9973-7E083AFBF181Q42150044-F07CA1E3-1BF5-4FBF-A96F-4152125B2B5EQ49829392-34D43980-957C-4674-8762-6872D3C14CE5
P2860
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
description
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Mai 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/05/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/05/01)
@nl
наукова стаття, опублікована в травні 2005
@uk
مقالة علمية (نشرت في مايو 2005)
@ar
name
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
@ast
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
@en
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
@nl
type
label
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
@ast
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
@en
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
@nl
prefLabel
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
@ast
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
@en
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
@nl
P2093
P1476
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection
@en
P2093
Allen Harmsen
Ann Harmsen
Mike Tighe
Nicole N. Meissner
Steve Swain
P304
P356
10.4049/JIMMUNOL.174.9.5462
P407
P577
2005-05-01T00:00:00Z